Vericel (VCEL) Profit After Tax (2010 - 2026)
Vericel (VCEL) reported Profit After Tax of -$6.3 million for Q1 2026, up 43.96% on a YoY basis from -$4.4 million in Q1 2025, and down 127.13% sequentially from $23.2 million in Q4 2025.
Vericel (VCEL) Profit After Tax (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 17 years of Profit After Tax data on file, last reported at -$6.3 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 43.96% year-over-year to -$6.3 million; the trailing twelve-month figure through Mar 2026 stood at $21.4 million (up 620.08% YoY), and the FY2025 full-year result was $16.5 million, up 59.24% from the prior year.
- Profit After Tax eased to -$6.3 million in Q1 2026, from $23.2 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $23.2 million in Q4 2025 to a low of -$11.2 million in Q1 2025.
- A 5-year average of $39352.9 and a median of -$3.9 million in 2024 frame the typical range for Profit After Tax.
- Peak annual rise in Profit After Tax reached 663.15% in 2025, while the deepest fall reached 191.2% in 2025.
- Tracing VCEL's Profit After Tax over 5 years: stood at $5.9 million in 2022, then surged by 119.4% to $13.0 million in 2023, then soared by 52.44% to $19.8 million in 2024, then advanced by 17.26% to $23.2 million in 2025, then plunged by 127.13% to -$6.3 million in 2026.
- Business Quant data shows VCEL's Profit After Tax at -$6.3 million in Q1 2026, $23.2 million in Q4 2025, and $5.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | -6.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.30 Mn |
| Dec 31, 2025 | 23.23 Mn |
| Sep 30, 2025 | 5.07 Mn |
| Jun 30, 2025 | -553,000.00 |
| Mar 31, 2025 | -11.25 Mn |
| Dec 31, 2024 | 19.81 Mn |
| Sep 30, 2024 | -901,000.00 |
| Jun 30, 2024 | -4.68 Mn |
| Mar 31, 2024 | -3.86 Mn |
| Dec 31, 2023 | 12.99 Mn |
| Sep 30, 2023 | -3.66 Mn |
| Jun 30, 2023 | -5.02 Mn |
| Mar 31, 2023 | -7.50 Mn |
| Dec 31, 2022 | 5.92 Mn |
| Sep 30, 2022 | -6.58 Mn |
| Jun 30, 2022 | -8.96 Mn |
| Mar 31, 2022 | -7.09 Mn |
| Dec 31, 2021 | 4.54 Mn |
| Sep 30, 2021 | -4.93 Mn |
| Jun 30, 2021 | -3.79 Mn |